Fujian Medical University Union Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website: http://www.fjxiehe.com/

Clinical Trials

Eravacycline Combination Therapy for MRAB

Recruiting

Conditions: Pulmonary Infection
Pneumonia, Bacterial
Acinetobacter Baumannii

Interventions: Drug: Eravacycline Injection

First Posted Date: 2024-02-28

Last Posted Date: 2024-02-28

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 20

Registration Number: NCT06282835

Locations: 🇨🇳
Fujian Medical University Union hospital, Fuzhou, Fujian, China

Stem Cell Derived Exosomes in the Treatment of Melasma and Its Percutaneous Penetration

Not Applicable

Recruiting

Conditions: Melasma

Interventions: Procedure: microneedles combined with hUCMSC-Exos
Procedure: 1565 nm non-ablative fractional laser combined with hUCMSC-Exos
Procedure: 1565 nm non-ablative fractional laser combined with normal saline
Procedure: PBASM combined with hUCMSC-Exos

First Posted Date: 2024-01-24

Last Posted Date: 2024-01-30

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 80

Registration Number: NCT06221787

Locations: 🇨🇳
Affiliated Union Hospital of Fujian Medical University, Fuzhou, Fujian, China

An Observational Study on the Quality of Life After Precise Lung Resection Through the Periareolar Incision

Recruiting

Conditions: Minimally Invasive Surgery
Surgical Incision

Interventions: Procedure: Type of surgical incision

First Posted Date: 2024-01-11

Last Posted Date: 2024-01-11

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 174

Registration Number: NCT06202053

Locations: 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China

Postoperative Immune Maintenance Therapy for Esophageal Squamous Cell Carcinoma After Radical Resection

Phase 3

Not yet recruiting

Conditions: Esophageal Squamous Cell Carcinoma Thoracic Stage IV
Esophageal Squamous Cell Carcinoma Thoracic Stage II
Esophageal Squamous Cell Carcinoma Thoracic Stage III

Interventions: Drug: sintilimab

First Posted Date: 2023-12-08

Last Posted Date: 2023-12-08

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 400

Registration Number: NCT06161909

Locations: 🇨🇳
Fujian, Fujian, China

Impact of a Predictive Model on Sentinel Lymph Node Biopsy in Initially Lymph Node-positive, HER2-positive Breast Cancer

Completed

Conditions: Breast Cancer
Sentinel Lymph Node

Interventions: Procedure: Test cohort

First Posted Date: 2023-11-29

Last Posted Date: 2023-12-13

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 716

Registration Number: NCT06149377

Locations: 🇨🇳
Chuan Wang, Fuzhou, Fujian, China

Comparing Innovative and Traditional Ventilation Strategies on Atelectasis and Prognosis in Elderly Patients

Not Applicable

Recruiting

Conditions: Atelectasis
Ventilator-associated Lung Injury
Postoperative Pulmonary Complications

Interventions: Procedure: Traditional ventilation strategies
Procedure: Traditional lung-protective ventilation strategies
Procedure: Lung-protective ventilation
Procedure: negative pressure extubation
Procedure: Innovative lung-protective ventilation strategies
Procedure: positive pressure extubation
Procedure: postoperative breathing training

First Posted Date: 2023-09-01

Last Posted Date: 2023-09-01

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 304

Registration Number: NCT06021249

Locations: 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
🇨🇳
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
🇨🇳
The First Hospital of Putian, Putian, Fujian, China

Postoperative Chronic Operation-related Symptoms After Minimally Invasive Lung Surgery

Recruiting

Conditions: Lung Cancer Stage I
Quality of Life

First Posted Date: 2023-08-30

Last Posted Date: 2023-11-18

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 500

Registration Number: NCT06016881

Locations: 🇨🇳
Maohui Chen, Fuzhou, Fujian, China

Personalized Optimization of Systematic Prostate Biopsy

Not Applicable

Recruiting

Conditions: Prostate Adenocarcinoma

Interventions: Procedure: Personalized Optimization of Systematic Prostate Biopsy

First Posted Date: 2023-08-18

Last Posted Date: 2024-11-28

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 664

Registration Number: NCT05998278

Locations: 🇨🇳
Department of Urology, Fujian Union Hospital, Fujian Medical University, Fuzhou, Fujian, China

Combined Segmentectomy Versus Lobectomy for Stage IA Lung Adenocarcinoma With Ground-glass Component of Prospective, Randomized, Controlled Clinical Study

Not Applicable

Active, not recruiting

Conditions: Combined Segmentectomy
IA Lung Adenocarcinoma

Interventions: Procedure: Patients receive subsegmentectomy

First Posted Date: 2023-08-09

Last Posted Date: 2023-08-09

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 688

Registration Number: NCT05983835

Locations: 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, China

Umbilical Cord Stem Cells for Skin Grafts in Donor Site Wounds

Not Applicable

Recruiting

Conditions: Skin Wound
Scar, Hypertrophic

Interventions: Procedure: human umbilical cord mesenchymal stem cells
Procedure: blank solvent

First Posted Date: 2023-08-09

Last Posted Date: 2023-10-24

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 88

Registration Number: NCT05984628

Locations: 🇨🇳
Chenxiaosong, Fujian, Fuzhou, China

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy